Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?

Circulation. 2020 Feb 25;141(8):637-640. doi: 10.1161/CIRCULATIONAHA.119.044770. Epub 2020 Feb 24.

Authors

Michael G Levin^{1

2}, Daniel J Rader^{2

3}

Affiliations

¹ Division of Cardiovascular Medicine (M.G.L.), University of Pennsylvania Perelman School of Medicine, Philadelphia.
² Department of Medicine (M.G.L., D.J.R.), University of Pennsylvania Perelman School of Medicine, Philadelphia.
³ Department of Genetics (D.J.R.), University of Pennsylvania Perelman School of Medicine, Philadelphia.

PMID: 32091922
DOI: 10.1161/CIRCULATIONAHA.119.044770

No abstract available

Keywords: Editorials; coronary artery disease; genome-wide association study; risk assessment.

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Coronary Artery Disease*
Humans
Multifactorial Inheritance

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
alirocumab